ALX Oncology Holdings Inc (NAS:ALXO)
$ 2.015 +0.035 (+1.77%) Market Cap: 278.63 Mil Enterprise Value: 150.10 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

ALX Oncology Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2026 / 08:00PM GMT
Release Date Price: $1.21 (-9.02%)
Henry Jiang
JPMorgan Chase & Co. - Analyst

Good afternoon. Thank you all for joining us here today. My name is Henry Jiang. I'm with the banking team here at JPMorgan, and it's my pleasure to be introducing ALX Oncology today. Joining us on stage and presenting today will be Jason Lettmann, CEO; as well as Barbara Klencke, Chief Medical Officer.

Just a reminder that we'll have time for questions at the end of the session. So please wait until then for any questions, and we'll get you a microphone.

But without further ado, I'll pass it over to you, Jason.

Jason Lettmann
ALX Oncology Holdings Inc - Chief Executive Officer, Director

Great. Thanks, Henry. Thanks for having us, and thanks to JPMorgan for the week, and appreciate you all spending some time. We heard that Thursday is the new Monday at JPMorgan. So thank you, thank you all.

Here are our forward-looking statements. So really excited to be here. We've had a really exciting week, I think, for ALX. We're coming off an incredible year for the company, a year in which we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot